Biologics Manufacturing Asia 2026: (SG BioPharma/ Academic)

The 13th Annual Biologics Manufacturing Asia 2026 is Asia’s premier bioprocessing-focused conference, providing a dedicated platform for regional biopharmaceutical industry stakeholders to network, explore strategic collaborations, and gain insights into the latest manufacturing technologies and advancements.This year’s agenda is designed to highlight success stories from Asia’s leading biopharma companies while incorporating technical expertise from global biopharma leaders, top pharmaceutical companies, and regulators. Key topics will include cutting-edge manufacturing technologies such as single-use systems and end-to-end continuous processing, challenges and opportunities in biomanufacturing, advancements in upstream process development, cost optimization and timeline reduction in downstream processing, analytical characterization strategies, facility design and scale-up, emerging biologics manufacturing technologies, regulatory updates, and novel biologics modalities.Building on the tremendous success of the 12th Annual Biologics Manufacturing Asia 2025, we are committed to delivering the most comprehensive and impactful knowledge-sharing platform at the 13th Annual Biologics Manufacturing Asia 2026.